Atabak Mokari - 30 Jul 2026 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Reporting relationship
Chief Financial Officer
Issuer ticker
CORT
Reported as of
30 Jul 2026
Net transaction value
-$9,177,109
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Aug 2026, 16:30:22 UTC
Prior SEC filing
17 Jul 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Atabak Mokari

Key filing fact

Atabak Mokari filed Form 4 for CORCEPT THERAPEUTICS INC (CORT) on 03 Aug 2026.

Key facts

  • This page summarizes Atabak Mokari's Form 4 filing for CORCEPT THERAPEUTICS INC (CORT).
  • 15 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Aug 2026, 16:30.

Change

  • Previous filing in this sequence was filed on 17 Jul 2026.
  • Current net transaction value: -$9,177,109.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001678419 Primary reporting owner

Mokari Atabak

Relationship
Chief Financial Officer
Address
C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Atabak Mokari
Signature date
03 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CORT transaction

Common Stock

Options Exercise

Transaction value
Shares
+80,000
Change %
+496%
Price
$23.06*
Shares after
96,130
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1
CORT transaction

Common Stock

Sale

Transaction value
$443,248
Shares
-4,200
Change %
-4.4%
Price
$105.54
Shares after
91,930
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F3
CORT transaction

Common Stock

Sale

Transaction value
$957,892
Shares
-8,956
Change %
-9.7%
Price
$106.96
Shares after
82,974
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F4
CORT transaction

Common Stock

Sale

Transaction value
$43,384
Shares
-400
Change %
-0.48%
Price
$108.46
Shares after
82,574
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2
CORT transaction

Common Stock

Sale

Transaction value
$242,282
Shares
-2,202
Change %
-2.7%
Price
$110.03
Shares after
80,372
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F5
CORT transaction

Common Stock

Sale

Transaction value
$66,570
Shares
-600
Change %
-0.75%
Price
$110.95
Shares after
79,772
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2
CORT transaction

Common Stock

Sale

Transaction value
$531,941
Shares
-4,700
Change %
-5.9%
Price
$113.18
Shares after
75,072
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F6
CORT transaction

Common Stock

Sale

Transaction value
$1,779,237
Shares
-15,477
Change %
-21%
Price
$114.96
Shares after
59,595
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F7
CORT transaction

Common Stock

Sale

Transaction value
$1,647,859
Shares
-14,222
Change %
-24%
Price
$115.87
Shares after
45,373
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F8
CORT transaction

Common Stock

Sale

Transaction value
$829,102
Shares
-7,089
Change %
-16%
Price
$116.96
Shares after
38,284
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F9
CORT transaction

Common Stock

Sale

Transaction value
$974,951
Shares
-8,267
Change %
-22%
Price
$117.93
Shares after
30,017
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F10
CORT transaction

Common Stock

Sale

Transaction value
$567,908
Shares
-4,783
Change %
-16%
Price
$118.73
Shares after
25,234
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F11
CORT transaction

Common Stock

Sale

Transaction value
$971,939
Shares
-8,103
Change %
-32%
Price
$119.95
Shares after
17,131
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F12
CORT transaction

Common Stock

Sale

Transaction value
$120,796
Shares
-1,001
Change %
-5.8%
Price
$120.67
Shares after
16,130
Date
30 Jul 2026
Ownership
Direct
Footnotes
F1, F2, F13

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CORT transaction Derivative

Stock option (right to buy)

Options Exercise

Transaction value
Shares
-80,000
Change %
-45%
Price
$0.000000*
Shares after
95,833
Date
30 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
80,000
Exercise price
$23.06
Footnotes
F14
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 14 footnotes

Footnote F1

Includes 200 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 2, 2025, 178 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2025, 397 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 2, 2026 and 634 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 1, 2026. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.

Footnote F2

This transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on December 12, 2025 in effect at the time of this transaction.

Footnote F3

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $105.305 to $106.2 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F4

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $106.75 to $107.195 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F5

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $109.71 to $110.42 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F6

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $112.96 to $113.89 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F7

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $114.305 to $115.30 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F8

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $115.35 to $116.27 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F9

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $116.35 to $117.3 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F10

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $117.41 to $118.39 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F11

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $118.42 to $119.21 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F12

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $119.42 to $120.41 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F13

Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $120.49 to $120.84 per share. Information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.

Footnote F14

Fully exercisable.

SEC remarks

The power of attorney under which this form was signed is on file with the Commission.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .